netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust

Looking for Alemtuzumab found 4 matches

Open monograph to display formulary status BNF Category
Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Feb 2020 MHRA DSU - Lemtrada▼ (alemtuzumab): updated restrictions and strengthened monitoring requirements following review of serious cardiovascular and immune-mediated reactions  (08.02.03)
link in drug section MHRA Drug Safety Update (May 2019):Lemtrada (alemtuzumab) and serious cardiovascular and immune-mediated adverse reactions (08.02.03)
link in drug section NICE TA312: Alemtuzumab for relapsing‑remitting multiple sclerosis (08.02.03)